phentermine has been researched along with Endomyocardial Fibrosis in 1 studies
Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
Endomyocardial Fibrosis: A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fowles, RE | 1 |
| Cloward, TV | 1 |
| Yowell, RL | 1 |
1 other study available for phentermine and Endomyocardial Fibrosis
| Article | Year |
|---|---|
Endocardial fibrosis associated with fenfluramine-phentermine.
Topics: Adult; Appetite Depressants; Drug Therapy, Combination; Endomyocardial Fibrosis; Female; Fenfluramin | 1998 |